In 2017, NIH awarded another $3 million grant to further develop the Hemanext ONE® RBC Processing and Storage System; the company also completed research that became the pivotal clinical study for obtaining CE Mark certification.
- Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa
- Impact of the Age of Blood
- Science Innovation Forum
- Hemanext Announces Partnership with Aplastic Anemia & MDS International Foundation
- Hemanext ONE Becomes First Blood Processing and Storage System to Receive Standards-Compliant Seal from AABB